| 2.31 Data as of May 17 |  +0.0762 / +3.42%Today’s Change | 1.45 Today|||52-Week Range 3.06 | +4.83% Year-to-Date |
| Previous close | 2.23 |
| Today’s open | 2.28 |
| Day’s range | 2.24 - 2.32 |
| Volume | 61,028 |
| Average volume (3 months) | 158,183 |
| Market cap | $85.6M |
| Dividend yield | -- |
| Earnings growth (last year) | +27.33% |
| Earnings growth (this year) | -155.20% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 11.92 |
| Today’s change | Today’s % change | |
|---|---|---|
| NNVCNanoViricides Inc | -0.02 | -3.49% |
| OGENOragenics Inc | 0.00 | 0.00% |
| DRRXDURECT Corp | -0.09 | -9.08% |
| CPIXCumberland Pharmaceu... | -0.01 | -0.20% |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$5.4M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
Executive Chairman & Chief Executive Officer Geoffrey Paul Kempler |
Chief Operating Officer Dianne Angus |
Corporate headquarters Parkville, Victoria (vic) |
.
